SCHEMBL19749201

SCHEMBL19749201

Cc1ccc(-n2c(C)cc(C(=O)CN(C)CCN(C)C)c2C)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.56
SMN1; SMN2 Q16637 9/20 0.54
HPGD P15428 2/20 0.54
RAB9A P51151 7/20 0.52
POLB P06746 1/20 0.52
HTT P42858 7/20 0.47
LMNA P02545 6/20 0.47
NPC1 O15118 5/20 0.47
ALDH1A1 P00352 4/20 0.47
MAPT P10636 4/20 0.47
TSHR P16473 3/20 0.47
TP53 P04637 3/20 0.47
KDM4E B2RXH2 3/20 0.47
NFKB1 P19838 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
KMT2A Q03164 3/20 0.47
MITF O75030 3/20 0.47
MEN1 O00255 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17949836 0.90 SMN1; SMN2 (0.58) NOTUMSMN1; SMN2HPGDRAB9AHTT
SCHEMBL6922486 0.90 ALDH1A1 (0.45) NOTUMSMN1; SMN2HPGDRAB9APOLB
SCHEMBL19501341 0.87 NOTUM (0.58) NOTUMSMN1; SMN2HPGDRAB9APOLB
SCHEMBL19501658 0.86 NOTUM (0.52) NOTUMSMN1; SMN2HPGDRAB9APOLB
SCHEMBL19501630 0.84 NOTUM (0.55) NOTUMSMN1; SMN2HPGDRAB9APOLB
SCHEMBL17949747 0.80 SMN1; SMN2 (0.58) NOTUMSMN1; SMN2HPGDRAB9AHTT
SCHEMBL19749190 0.80 SMN1; SMN2 (0.46) NOTUMSMN1; SMN2HPGDRAB9APOLB
SCHEMBL6922796 0.80 SMN1; SMN2 (0.46) NOTUMSMN1; SMN2HPGDRAB9APOLB
SCHEMBL19501172 0.79 NOTUM (0.44) NOTUMSMN1; SMN2HPGDRAB9APOLB
SCHEMBL6923276 0.77 ALDH1A1 (0.50) NOTUMSMN1; SMN2HPGDRAB9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10351568-B2 Compositions and methods for enhancing proteasome activity PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2019-07-16 US disclosed
US-9849135-B2 USP14 inhibitors for treating or preventing viral infections PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2017-12-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10351568-B2 Compositions and methods for enhancing proteasome activity PSMG3, PSME3, PSMB11 NOTUM 2331/4885SMN1; SMN2 307/4885HPGD 4170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.